Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Portopulmonary hypertension: imatinib as a novel treatment and the Emory experience with this condition.

Portopulmonary hypertension: imatinib as a novel treatment and the Emory experience with this condition. Transplant Proc. 2009 Jun; 41(5):1969-71.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.